BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22868769)

  • 41. Phage display selection of ligand residues important for Src homology 3 domain binding specificity.
    Rickles RJ; Botfield MC; Zhou XM; Henry PA; Brugge JS; Zoller MJ
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10909-13. PubMed ID: 7479908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck.
    Briggs SD; Bryant SS; Jove R; Sanderson SD; Smithgall TE
    J Biol Chem; 1995 Jun; 270(24):14718-24. PubMed ID: 7782336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding mechanism of an SH3 domain studied by NMR and ITC.
    Demers JP; Mittermaier A
    J Am Chem Soc; 2009 Apr; 131(12):4355-67. PubMed ID: 19267471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemical shift assignments of the partially deuterated Fyn SH2-SH3 domain.
    Kieken F; Loth K; van Nuland N; Tompa P; Lenaerts T
    Biomol NMR Assign; 2018 Apr; 12(1):117-122. PubMed ID: 29224116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
    Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T
    FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
    Hunter S; Burton EA; Wu SC; Anderson SM
    J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel Src homology 3 domain-binding motifs identified from proteomic screen of a Pro-rich region.
    Jia CY; Nie J; Wu C; Li C; Li SS
    Mol Cell Proteomics; 2005 Aug; 4(8):1155-66. PubMed ID: 15929943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-resolution crystal structure of spectrin SH3 domain fused with a proline-rich peptide.
    Gushchina LV; Gabdulkhakov AG; Nikonov SV; Filimonov VV
    J Biomol Struct Dyn; 2011 Dec; 29(3):485-95. PubMed ID: 22066535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.
    Patel HV; Tzeng SR; Liao CY; Chen SH; Cheng JW
    Proteins; 1997 Dec; 29(4):545-52. PubMed ID: 9408950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetics of Src homology 3 domain association with the proline-rich domain of dynamins: specificity, occlusion, and the effects of phosphorylation.
    Solomaha E; Szeto FL; Yousef MA; Palfrey HC
    J Biol Chem; 2005 Jun; 280(24):23147-56. PubMed ID: 15834155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C virus NS5A is able to competitively displace c-Myc from the Bin1 SH3 domain in vitro.
    Aladag A; Hoffmann S; Stoldt M; Bösing C; Willbold D; Schwarten M
    J Pept Sci; 2014 May; 20(5):334-40. PubMed ID: 24616074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.
    Arold S; O'Brien R; Franken P; Strub MP; Hoh F; Dumas C; Ladbury JE
    Biochemistry; 1998 Oct; 37(42):14683-91. PubMed ID: 9778343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
    Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergy and allostery in ligand binding by HIV-1 Nef.
    Aldehaiman A; Momin AA; Restouin A; Wang L; Shi X; Aljedani S; Opi S; Lugari A; Shahul Hameed UF; Ponchon L; Morelli X; Huang M; Dumas C; Collette Y; Arold ST
    Biochem J; 2021 Apr; 478(8):1525-1545. PubMed ID: 33787846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SAP couples Fyn to SLAM immune receptors.
    Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
    Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain.
    Hane M; Lowin B; Peitsch M; Becker K; Tschopp J
    FEBS Lett; 1995 Oct; 373(3):265-8. PubMed ID: 7589480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
    Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
    Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55.
    Kang H; Freund C; Duke-Cohan JS; Musacchio A; Wagner G; Rudd CE
    EMBO J; 2000 Jun; 19(12):2889-99. PubMed ID: 10856234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding of Fyn to MAP-2c through an SH3 binding domain. Regulation of the interaction by ERK2.
    Zamora-Leon SP; Lee G; Davies P; Shafit-Zagardo B
    J Biol Chem; 2001 Oct; 276(43):39950-8. PubMed ID: 11546790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.